Dr. Hafez M. Abdullah, MD
Hematology & Oncology (Hematology & Oncology Physician)
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2017
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
OH license 35.156721 · NE license 35560 -
Hospitalist Physician
SD license 12066
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mary Lanning Healthcare Hastings, NE
- Grand Island Regional Medical Center Grand Island, NE
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 300 | 95 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 79 | 68 |
| Hospital discharge day management, more than 30 minutes | 73 | 70 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $387 in total to this clinician.
| GlaxoSmithKline, LLC. | $101 |
|---|---|
| AbbVie Inc. | $99.99 |
| Incyte Corporation | $95.95 |
| AstraZeneca Pharmaceuticals LP | $90.00 |
| Education | $196 |
|---|---|
| Food and Beverage | $191 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Jan 22, 2025 | Education VENCLEXTA · ONCOLOGY · in-kind | $99.99 |
| Incyte Corporation Apr 30, 2025 | Education | $95.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.